Home Medicine Clinical validation of a liquid chromatography single quadrupole mass spectrometry (LC-MS) method using Waters Kairos™ Amino Acid Kit reagents
Article
Licensed
Unlicensed Requires Authentication

Clinical validation of a liquid chromatography single quadrupole mass spectrometry (LC-MS) method using Waters Kairos™ Amino Acid Kit reagents

  • Rowan Hellier , Luke Griffiths , Chandra Sundas , Annabel Rodham and Stuart J. Moat EMAIL logo
Published/Copyright: August 8, 2025

Abstract

Objectives

Quantitation of plasma amino acids (AA) is critical for the diagnosis and monitoring of inherited disorders of AA metabolism. AA analysis using ion-exchange chromatography (IEC) with post-column ninhydrin derivatization is time consuming, with run times of ∼2 h, limiting sample throughput. Liquid chromatography mass-spectrometry can potentially address some of the current challenges.

Methods

Performance of components of the Waters Kairos Amino Acid Kit using liquid chromatography single quadrupole mass-spectrometry (LC-MS) following derivatization of samples with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate (AccQ•Tag™ Ultra Derivatization Reagent) was evaluated. Results were compared with the Biochrom-IEC method using patient specimens (n=115), ClinChek® control and external quality assessment (EQA) material.

Results

The kit reagents and our developed method had a 19-min analysis time, demonstrated acceptable inter-assay imprecision (CV<10 %) and bias vs. IEC-method (overall mean bias <2 %). Excellent correlation (concordance correlation coefficient (CCC) >0.99) with IEC was demonstrated for 10/23 analytes, good correlation (CCC >0.95) for 10/23, with the remaining three amino acids (aspartate, histidine and tryptophan) demonstrating moderate concordance (CCC ≥0.90 but <0.95). 1/23 AAs had a mean bias >10 % using EQA material. The method demonstrated a lower limit of quantitation of ≤2.5 μmol/L for all AA, making this assay suitable for CSF analysis. Calibration stability bias was <5 % over 12-weeks. Derivatized AAs were stable for ≤17 days. The analytical column supplied demonstrated good retention time stability (<0.4 %) and was capable of >2000 injections.

Conclusions

The tested methodology demonstrated good analytical performance and correlation with IEC. This approach confers practical advantages over IEC, including analytical selectivity and workflow time efficiency.


Corresponding author: Stuart J. Moat, Department of Medical Biochemistry, Immunology and Toxicology, University Hospital of Wales, Cardiff, Wales, CF14 4XW, UK; and School of Medicine, Cardiff University, Cardiff, Wales, UK, E-mail:

Acknowledgments

The reagent kits were received as a gift from Waters for the evaluation. The authors thank Peter Christensen, Padhraic Rossiter, Adam Cryar, Alex Hunt, Lisa Calton and Heather Brown from Waters for technical support and scientific advice. The authors would like to thank Grace Heffernan, of Waters Wexford, who were instrumental in the development and manufacture of the kit and materials provided for the evaluation. SJM is supported by the UK Medical Research Council-Rare Disease Research Platform grant number MR/Y008057/1.

  1. Research ethics: Not applicable.

  2. Informed consent: Not applicable.

  3. Author contributions: SJM, conceived and planned the study. SJM and RH wrote the first draft of the manuscript. RH, LG, CS and AR undertook sample processing, performed all the laboratory analyses. All authors have accepted responsibility for the entire content of this manuscript and approved its submission.

  4. Use of Large Language Models, AI and Machine Learning Tools: None declared.

  5. Conflict of interest: The authors state no conflict of interest.

  6. Research funding: None declared.

  7. Data availability: Not applicable.

References

1. Walker, V, Mills, G. Quantitative methods for amino acid analysis in biological fluids. Ann Clin Biochem 1995;32:28–57. https://doi.org/10.1177/000456329503200103.Search in Google Scholar PubMed

2. Song, Y, Xu, C, Kuroki, H, Liao, Y, Tsunoda, M. Recent trends in analytical methods for the determination of amino acids in biological samples. J Pharm Biomed Anal 2018;147:35–49. https://doi.org/10.1016/j.jpba.2017.08.050.Search in Google Scholar PubMed

3. Carling, RS, John, K, Churchus, R, Turner, C, Dalton, RN. Validation of a rapid comprehensive and clinically relevant amino acid profile by liquid chromatography tandem mass spectrometry. Clin Chem Lab Med 2020;58:758–68. https://doi.org/10.1515/cclm-2019-0604.Search in Google Scholar PubMed

4. Dietzen, DJ, Weindel, AL, Carayannopoulos, MO, Landt, M, Normansell, ET, Reimschisel, TE, et al.. Rapid comprehensive amino acid analysis by liquid chromatography/tandem mass spectrometry: comparison to cation exchange with post-column ninhydrin detection. Rapid Commun Mass Spectrom 2008;22:3481–8. https://doi.org/10.1002/rcm.3754.Search in Google Scholar PubMed

5. Phipps, WS, Crossley, E, Boriack, R, Jones, PM, Patel, K. Quantitative amino acid analysis by liquid chromatography-tandem mass spectrometry using low cost derivatisation and an automated liquid handler. JIMD Reports 2020;51:62–9. https://doi.org/10.1002/jmd2.12080.Search in Google Scholar PubMed PubMed Central

6. Smon, A, Cuk, V, Brecelj, J, Murko, S, Groselj, U, Zerjav Tansek, M, et al.. Comparison of liquid chromatography with tandem mass spectrometry and ion-exchange chromatography by post-column ninhydrin derivatization for amino acid monitoring. Clin Chim Acta 2019;495:446–5. https://doi.org/10.1016/j.cca.2019.05.007.Search in Google Scholar PubMed

7. Carling, RS, McDonald, BAC, Austin, D, Burden, D, Correia, J, Leung, J, et al.. Challenging the status quo: a comparison of ion exchange chromatography with liquid chromatography–mass spectrometry and liquid chromatography–tandem mass spectrometry methods for the measurement of amino acids in human plasma. Ann Clin Biochem 2020;4:277–90. https://doi.org/10.1177/0004563220933303.Search in Google Scholar PubMed

8. Piraud, M, Vianey-Saban, C, Petritis, K, Elfakir, C, Steghens, J, Bouchu, D. Ion-pairing reversed-phase liquid chromatography/electrospray ionization mass spectrometric analysis of 76 underivatized amino acids of biological interest: a new tool for the diagnosis of inherited disorders of amino acid metabolism. Rapid Commun Mass Spectrom 2005;19:1587–602. https://doi.org/10.1002/rcm.1957.Search in Google Scholar PubMed

9. Prinsen, H, Schiebergen-Bronkhorst, B, Roeleveld, M, Jans, J, de Sain-van der Velden, M, Visser, G, et al.. Rapid quantification of underivatized amino acids in plasma by hydrophilic interaction liquid chromatography (HILIC) coupled with tandem mass-spectrometry. J Inherit Metab Dis 2016;39:651–60. https://doi.org/10.1007/s10545-016-9935-z.Search in Google Scholar PubMed PubMed Central

10. Salazar, C, Armenta, JM, Cortes, DF, Shulaev, V. Combination of an AccQ•Tag-ultra performance liquid chromatography method with tandem mass spectrometry for the analysis of amino acids. Methods Mol Biol 2012;828:13–28.10.1007/978-1-61779-445-2_2Search in Google Scholar PubMed

11. Pretorius, CJ, McWhinney, BC, Sipinkoski, B, Wilce, A, Cox, D, McWhinney, A, et al.. Rapid amino acid quantitation with pre-column derivatization; ultra-performance reverse phase liquid chromatography and single quadrupole mass spectrometry. Clin Chim Acta 2018;478:132–9. https://doi.org/10.1016/j.cca.2017.12.027.Search in Google Scholar PubMed

12. Bruno, C, Veyrat-Durebex, C, Lumbu Lukuntonda, CH, Andres, CR, Moreau, C, Bendavid, C, et al.. Validation of plasma amino acid profile using UHPLC-mass spectrometer (QDa) as a screening method in a metabolic disorders reference centre: performance and accreditation concerns. Clin Biochem 2021;92:34–45. https://doi.org/10.1016/j.clinbiochem.2021.03.004.Search in Google Scholar PubMed

13. Passing, HB, Bablok, W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry. Part I. J Clin Chem Clin Biochem 1983;21:709–20. https://doi.org/10.1515/cclm.1983.21.11.709.Search in Google Scholar PubMed

14. Lin, LA. A concordance correlation coefficient to evaluate reproducibility. Biometrics 1989;45:255–68. https://doi.org/10.2307/2532051.Search in Google Scholar

15. Liao, J, Lewis, JW. A note on concordance correlation coefficient. PDA J Pharm Sci Technol 2000;54:23–6.Search in Google Scholar

16. Parvy, P, Bardet, J, Gasquet, M, Rabier, D, Kamoun, SP. Stability of free amino acids in sulfosalicylic filtrates. Clin Chem 1995;41:465–6. https://doi.org/10.1093/clinchem/41.3.465.Search in Google Scholar

17. Friedman, M, Finley, J. Methods of tryptophan analysis. J Agric Food Chem 1972;19:626–31. https://doi.org/10.1021/jf60176a010.Search in Google Scholar PubMed

18. van der Crabben, SN, Verhoeven-Duif, NM, Brilstra, EH, Van Maldergem, L, Coskun, T, Rubio-Gozalbo, E, et al.. An update on serine deficiency disorders. J Inherit Metab Dis 2013;36:613–9. https://doi.org/10.1007/s10545-013-9592-4.Search in Google Scholar PubMed

19. Alfadhel, M, Alrifai, MT, Trujillano, D, Alshaalan, H, Al Othaim, A, Al Rasheed, S, et al.. Asparagine synthetase deficiency: new inborn errors of metabolism. JIMD Rep 2015;22:11–16. https://doi.org/10.1007/8904_2014_405.Search in Google Scholar PubMed PubMed Central

20. Tangeraas, T, Constante, JR, Backe, PH, Oyarzábal, A, Neugebauer, J, Weinhold, N, et al.. BCKDK deficiency: a treatable neurodevelopmental disease amenable to newborn screening. Brain 2023;146:3003–13.21. https://doi.org/10.1093/brain/awad010.Search in Google Scholar PubMed

21. Moat, SJ, Carling, R, Nix, A, Henderson, M, Briddon, A, Prunty, H, et al.. Multicentre age-related reference intervals for cerebrospinal fluid serine concentrations: implications for the diagnosis and follow-up of serine biosynthesis disorders. Mol Genet Metabol 2010;101:149–52. https://doi.org/10.1016/j.ymgme.2010.07.006.Search in Google Scholar PubMed


Supplementary Material

This article contains supplementary material (https://doi.org/10.1515/cclm-2025-0424).


Received: 2025-04-04
Accepted: 2025-07-21
Published Online: 2025-08-08
Published in Print: 2025-10-27

© 2025 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Advancing diagnostic stewardship through claims-based utilization analysis: toward a system-wide vision of diagnostic excellence
  4. Review
  5. Biomarkers in body fluids and their detection techniques for human intestinal permeability assessment
  6. Mini Review
  7. Challenges of using natriuretic peptides to screen for the risk of developing heart failure in patients with diabetes: a report from the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) Committee on Clinical Applications of Cardiac Bio-Markers (C-CB)
  8. Opinion Papers
  9. Reference intervals in value-based laboratory medicine: a shift from single-point measurements to metabolic variation-based models
  10. Overview of laboratory diagnostics for immediate management of patients presenting to the emergency department with acute bleeding
  11. What Matters Most: an Age-Friendly approach to pathology and laboratory medicine
  12. No fault or negligence after an adverse analytical finding due to a contaminated supplement: mission impossible. Two examples involving trimetazidine
  13. General Clinical Chemistry and Laboratory Medicine
  14. Utilization analysis of laboratory tests using health insurance claims data: advancing nationwide diagnostic stewardship monitoring systems
  15. Evaluating large language models as clinical laboratory test recommenders in primary and emergency care: a crucial step in clinical decision making
  16. A novel corrective model based on red blood cells indices and haemolysis index enables accurate unhaemolysed potassium determination in haemolysed samples – Hemokalc project
  17. Validation of (self-collected) capillary blood using a topper collection system as alternative for venous sampling for 15 common clinical chemistry analytes
  18. Acoustophoresis-based blood sampling and plasma separation for potentially minimizing sampling-related blood loss
  19. Clinical validation of a liquid chromatography single quadrupole mass spectrometry (LC-MS) method using Waters Kairos™ Amino Acid Kit reagents
  20. Robustness of steroidomics-based machine learning for diagnosis of primary aldosteronism: a laboratory medicine perspective
  21. Investigation of the possible cause of over-estimation of human aldosterone in plasma, using a unique, non-synthetic human aldosterone-free matrix
  22. Performance of afternoon (16:00 h) serum cortisol for the diagnosis of Cushing’s syndrome
  23. MAGLUMI® Tacrolimus (CLIA) assay: analytical performances and comparison with LC-MS/MS and ARCHITECT Tacrolimus (CMIA) assay
  24. Assessment of 2023 ACR/EULAR antiphospholipid syndrome classification criteria in a Spanish cohort
  25. Comprehensive evaluation of antiphospholipid antibody testing methodologies in APS diagnosis: performance comparisons across assay systems and clinical subtypes
  26. Candidate Reference Measurement Procedures and Materials
  27. Exploring commutable materials for serum folate measurement: challenges in cross-method harmonization
  28. Reference Values and Biological Variations
  29. Reference ranges for ionized calcium in plasma in Danish children aged 0 days to 3 years using laboratory registry data
  30. A step forward in pediatric hemophagocytic lymphohistiocytosis and autoimmune disease: pediatric reference interval for serum soluble IL-2 receptor and soluble CD163
  31. Cancer Diagnostics
  32. Cellular expression of PD-1, PD-L1 and CTLA-4 in patients with JAK2V617F mutated myeloproliferative disorders
  33. Diabetes
  34. Serum N-glycans as independent predictors of the incidence of type 2 diabetes: a prospective investigation in the AEGIS cohort
  35. Infectious Diseases
  36. An assessment of molecular diagnosis of tuberculosis and multi-drug resistant tuberculosis testing and quality assessment: findings of an international survey
  37. Letters to the Editor
  38. Targeting low-value laboratory care
  39. Is time a significant factor in the release of potassium from lithium heparin plasma and serum?
  40. External quality assessment in resource-constrained laboratories: a survey of practices and perceptions in Nepal
  41. Is successfulness of platelet clump disaggregation by vortexing influenced by platelet measurement methods?
  42. Oligoclonal banding analysis: assessing plasma use and time interval requirements for paired CSF and blood
Downloaded on 1.1.2026 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2025-0424/html
Scroll to top button